AURA
Aura Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Largest filed tie
0
filed ties
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+4.42%
vs ±83.3% implied · ×0.05
shaded = implied · ▲▼ = realized
No thesis.
Aura Biosciences, Inc.
5.98
−0.16 · −2.54%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | TCG Crossover ManagementTCG Crossover | $67.7M | 9.98% | new | |
| 2 | Suvretta Capital ManagementSuvretta | $51.2M | 7.54% | +64.79% | |
| 3 | Frazier Life Sciences ManagementFrazier Life Sciences | $50.4M | 7.43% | +39.22% | |
| 4 | Long Focus Capital ManagementLong Focus | $36.3M | 5.36% | +10.82% | |
| 5 | BlackRockBlackRockindex-like | $33.4M | 4.93% | +31.26% | |
| 6 | Adage Capital Partners GPAdage Capital Partners GP | $32.9M | 4.86% | −4.94% | |
| 7 | Caligan PartnersCaligan Partners | $30.5M | 4.50% | +1769.91% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $29.1M | 4.29% | +82.74% | |
| 9 | Fcpm III Services B.V.Fcpm III Services B.V. | $28.8M | 4.24% | new | |
| 10 | Orbimed AdvisorsOrbimed | $23.7M | 3.49% | new | |
| 11 | Medicxi Ventures Management (Jersey)Medicxi Ventures Management (Jersey) | $21.6M | 3.18% | 0.00% | |
| 12 | Nantahala Capital ManagementNantahala | $21.0M | 3.09% | +39.35% | |
| 13 | Jupiter TopcoJupiter Topco | $17.8M | 2.62% | — | |
| 14 | RA Capital ManagementRA Capital Management | $17.8M | 2.62% | new | |
| 15 | Balyasny Asset ManagementBalyasny | $16.7M | 2.46% | +322.24% | |
| 16 | Franklin ResourcesFranklin Resources | $14.7M | 2.17% | 0.00% | |
| 17 | Geode Capital ManagementGeodeindex-like | $12.5M | 1.84% | +33.86% | |
| 18 | Redmile GroupRedmile | $11.8M | 1.74% | new | |
| 19 | EcoR1 CapitalEcoR1 Capital | $11.8M | 1.74% | new | |
| 20 | Trails Edge Capital PartnersTrails Edge Capital Partners | $10.2M | 1.51% | new | |
| 21 | Foresite Capital Management VIForesite Capital Management VI | $9.5M | 1.40% | new | |
| 22 | State StreetState Streetindex-like | $8.7M | 1.28% | +26.78% | |
| 23 | Woodline PartnersWoodline Partners | $8.6M | 1.27% | new | |
| 24 | Bellevue GroupBellevue | $8.3M | 1.22% | new | |
| 25 | Vivo CapitalVivo Capital | $8.3M | 1.22% | new |
148 managers report $678.4M of Aura Biosciences on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; TCG Crossover is largest at 9.98%.
Expected move
No implied move.
No implied move.
No implied move.